Seniors’ Access to Critical Medications Act of 2024
USA118th CongressHR-5526| House
| Updated: 9/24/2024
Diana Harshbarger
Republican Representative
Tennessee
Cosponsors (69)
Michael C. Burgess (Republican)David Kustoff (Republican)Jared F. Golden (Democratic)John R. Carter (Republican)Chris Pappas (Democratic)Marie Gluesenkamp Perez (Democratic)Abigail Davis Spanberger (Democratic)Lisa Blunt Rochester (Democratic)Gregory F. Murphy (Republican)Darren Soto (Democratic)Raul Ruiz (Democratic)Jefferson Van Drew (Republican)Neal P. Dunn (Republican)Thomas P. Tiffany (Republican)Darin LaHood (Republican)Mariannette Miller-Meeks (Republican)Terri A. Sewell (Democratic)Dina Titus (Democratic)David Rouzer (Republican)Steve Cohen (Democratic)Jeff Duncan (Republican)Paul Tonko (Democratic)
Ways and Means Committee, Finance Committee, Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Forwarded by Subcommittee to Full Committee by the Yeas and Nays: 19 - 6.
Subcommittee Consideration and Mark-up Session Held
Ordered to be Reported (Amended) by the Yeas and Nays: 41 - 0.
Committee Consideration and Mark-up Session Held
Placed on the Union Calendar, Calendar No. 585.
Committee on Ways and Means discharged.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-691, Part I.
Mr. Bucshon moved to suspend the rules and pass the bill, as amended.
Considered under suspension of the rules. (consideration: CR H5587-5588)
DEBATE - The House proceeded with forty minutes of debate on H.R. 5526.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5587)
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5587)
Motion to reconsider laid on the table Agreed to without objection.
The title of the measure was amended. Agreed to without objection.
Received in the Senate and Read twice and referred to the Committee on Finance.
Health
Government information and archivesInternet, web applications, social mediaMedicarePrescription drugs
Seniors’ Access to Critical Medications Act of 2024
USA118th CongressHR-5526| House
| Updated: 9/24/2024
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Forwarded by Subcommittee to Full Committee by the Yeas and Nays: 19 - 6.
Subcommittee Consideration and Mark-up Session Held
Ordered to be Reported (Amended) by the Yeas and Nays: 41 - 0.
Committee Consideration and Mark-up Session Held
Placed on the Union Calendar, Calendar No. 585.
Committee on Ways and Means discharged.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-691, Part I.
Mr. Bucshon moved to suspend the rules and pass the bill, as amended.
Considered under suspension of the rules. (consideration: CR H5587-5588)
DEBATE - The House proceeded with forty minutes of debate on H.R. 5526.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5587)
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5587)
Motion to reconsider laid on the table Agreed to without objection.
The title of the measure was amended. Agreed to without objection.
Received in the Senate and Read twice and referred to the Committee on Finance.
Diana Harshbarger
Republican Representative
Tennessee